rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector

Overview of attention for article published in PLOS ONE, November 2008

Altmetric Badge

Mentioned by

policy: 1 policy source

patent: 5 patents

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

RECOMBINANT MODIFIED saRNA (VRP) AND VACCINIA VIRUS ANKARA (MVA) PRIME-BOOST REGIMEN

Application WO-2024003239-A1

World Intellectual Property Organisation (WIPO)

04 Jan 2024

Stable, spray dried, immunogenic, viral compositions

Grant US-11446373-B2

United States of America

20 Sep 2022

Stable, spray dried, immunogenic, viral compositions

Grant US-10736953-B2

United States of America

11 Aug 2020

Adeno-associated-virus Rep sequences, vectors and viruses

Grant US-10214730-B2

United States of America

26 Feb 2019

Stable, spray dryed, immunogenic, viral compositions

Grant US-9610343-B2

United States of America

04 Apr 2017

PLOS

Article Metrics

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector

Mentioned by

Citations

Readers on

RECOMBINANT MODIFIED saRNA (VRP) AND VACCINIA VIRUS ANKARA (MVA) PRIME-BOOST REGIMEN

Application WO-2024003239-A1

World Intellectual Property Organisation (WIPO)

Stable, spray dried, immunogenic, viral compositions

Grant US-11446373-B2

United States of America

Stable, spray dried, immunogenic, viral compositions

Grant US-10736953-B2

United States of America

Adeno-associated-virus Rep sequences, vectors and viruses

Grant US-10214730-B2

United States of America

Stable, spray dryed, immunogenic, viral compositions

Grant US-9610343-B2

United States of America